Maynard Um
-
-
-
-
-
-
-
'Omnicell (OMCL) Remaining One of Our Top Ideas'; PT Raised to $70 at KeyBanc
-
-
-
-
-
-
-
Omnicell (OMCL) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 Guidance
-
-
-
-
-
-
-
Omnicell (OMCL) PT Raised to $50 at Benchmark
-
-
-
-
-
-
-
Omnicell (OMCL) PT Lowered to $55 at Piper Sandler Despite Guide Raise
-
-
-
-
-
-
-
Omnicell (OMCL) Announces New Products for Perioperative and Clinic Settings
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
441,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

